These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 26060814)
1. A survey on the computational approaches to identify drug targets in the postgenomic era. Dai YF; Zhao XM Biomed Res Int; 2015; 2015():239654. PubMed ID: 26060814 [TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
3. A survey on computational approaches to identifying disease biomarkers based on molecular networks. Qin G; Zhao XM J Theor Biol; 2014 Dec; 362():9-16. PubMed ID: 24931674 [TBL] [Abstract][Full Text] [Related]
4. Using genomics to develop novel antibacterial therapeutics. Nagaraj NS; Singh OV Crit Rev Microbiol; 2010 Nov; 36(4):340-8. PubMed ID: 20670176 [TBL] [Abstract][Full Text] [Related]
5. Computational chemogenomics approaches to systematic knowledge-based drug discovery. Mestres J Curr Opin Drug Discov Devel; 2004 May; 7(3):304-13. PubMed ID: 15216933 [TBL] [Abstract][Full Text] [Related]
6. Rational drug design. Mandal S; Moudgil M; Mandal SK Eur J Pharmacol; 2009 Dec; 625(1-3):90-100. PubMed ID: 19835861 [TBL] [Abstract][Full Text] [Related]
7. Using bioinformatics for drug target identification from the genome. Jiang Z; Zhou Y Am J Pharmacogenomics; 2005; 5(6):387-96. PubMed ID: 16336003 [TBL] [Abstract][Full Text] [Related]
8. Functional screening revisited in the postgenomic era. Tochitani S; Hayashizaki Y Mol Biosyst; 2007 Mar; 3(3):195-207. PubMed ID: 17308666 [TBL] [Abstract][Full Text] [Related]
9. Chemical genomics as an emerging paradigm for postgenomic drug discovery. Salemme FR Pharmacogenomics; 2003 May; 4(3):257-67. PubMed ID: 12718717 [TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling in drug discovery and development. Stratowa C; Wilgenbus KK Curr Opin Mol Ther; 1999 Dec; 1(6):671-9. PubMed ID: 19629863 [TBL] [Abstract][Full Text] [Related]
11. In silico analyses for the discovery of tuberculosis drug targets. Chung BK; Dick T; Lee DY J Antimicrob Chemother; 2013 Dec; 68(12):2701-9. PubMed ID: 23838951 [TBL] [Abstract][Full Text] [Related]
12. Where are we in genomics? Hocquette JF J Physiol Pharmacol; 2005 Jun; 56 Suppl 3():37-70. PubMed ID: 16077195 [TBL] [Abstract][Full Text] [Related]
13. Structure-based approaches to antibiotic drug discovery. Nicola G; Abagyan R Curr Protoc Microbiol; 2009 Feb; Chapter 17():Unit17.2. PubMed ID: 19235149 [TBL] [Abstract][Full Text] [Related]
14. Advancing drug discovery through systems biology. Davidov E; Holland J; Marple E; Naylor S Drug Discov Today; 2003 Feb; 8(4):175-83. PubMed ID: 12581712 [TBL] [Abstract][Full Text] [Related]
15. A review of network-based approaches to drug repositioning. Lotfi Shahreza M; Ghadiri N; Mousavi SR; Varshosaz J; Green JR Brief Bioinform; 2018 Sep; 19(5):878-892. PubMed ID: 28334136 [TBL] [Abstract][Full Text] [Related]
16. Biomedical data integration in computational drug design and bioinformatics. Seoane JA; Aguiar-Pulido V; Munteanu CR; Rivero D; Rabunal JR; Dorado J; Pazos A Curr Comput Aided Drug Des; 2013 Mar; 9(1):108-17. PubMed ID: 23294434 [TBL] [Abstract][Full Text] [Related]